ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Genomic characteristics and drug screening among organoids derived fromnon-small celllung cancer patients

Chen, Jing-Hua; Chu, Xiang-Peng; Zhang, Jia-Tao; Nie, Qiang; Tang, Wen-Fang; Su, Jian; Yan, Hong-Hong; Zheng, Hong-Ping; Chen, Ze-Xin; Chen, Xin; Song, Meng-Meng; Yi, Xin; Li, Pan-Song; Guan, Yan-Fang; Li, Gang; Deng, Chu-Xia; Rosell, Rafael; Wu, Yi-Long; Zhong, Wen-Zhao*广东省人民医院; 南方医科大学; 汕头大学
Thoracic Cancer2020-8DOI: 10.1111/1759-7714.13542
33被引9阅读
引用收藏
分享

摘要

Background Patient-derived organoid (PDO) models are highly valuable and have potentially widespread clinical applications. However, limited information is available regarding organoid models of non-small cell lung cancer (NSCLC). This study aimed to characterize the consistency between primary tumors in NSCLC and PDOs and to explore the applications of PDOs as preclinical models to understand and predict treatment response during lung cancer. Methods Fresh tumor samples were harvested for organoid culture. Primary tumor samples and PDOs were analyzed via whole-exome sequencing. Paired samples were subjected to immunohistochemical analysis. There were 26 antineoplastic drugs tested in the PDOs. Cell viability was assessed using the Cell Titer Glo assay 7-10 days after drug treatment. A heatmap of log-transformed values of the half-maximal inhibitory concentrations was generated on the basis of drug responses of PDOs through nonlinear regression (curve fit). A total of 12 patients (stages I-III) were enrolled, and 7 paired surgical tumors and PDOs were analyzed. Results PDOs retained the histological and genetic characteristics of the primary tumors. The concordance between tumors and PDOs in mutations in the top 20 NSCLC-related genes was >80% in five patients. Sample purity was significantly and positively associated with variant allele frequency (Pearsonr= 0.82,P= 0.0005) and chromosome stability. The in vitro response to drug screening with PDOs revealed high correlation with the mutation profiles in the primary tumors. Conclusions PDOs are highly credible models for detecting NSCLC and for prospective prediction of the treatment response for personalized precision medicine. Key points Lung cancer organoid models could save precious time of drug testing on patients, and accurately select anticancer drugs according to the drug sensitivity results, so as to provide a powerful supplement and verification for the gene sequencing.

学科与关键词

关键词
Consistency analysisdrug screeningnon-small cell lung cancerpatient-derived organoidwhole exome sequencing
相关
加载中…

文献加载失败,请重试

重试

发表信息

论文状态
公开发表
期刊
Thoracic Cancer
发表日期
2020-08
卷期
第 11 卷, 第 8 期
页码
2279-2290
DOI
10.1111/1759-7714.13542
语言
ENGLISH
期刊收录
NSL.SCIE
期刊等级
3区
成果收录
SCIE
资助标注
National Natural Science Foundation of China [81673031, 81872510]; Health Collaborative Innovation Major Project from Guangzhou Science and Technology Bureau [201704020161]; High-level Hospital Construction Project from Guangdong Health Commission [DFJH201801]; Guangdong Provincial People's Hospital Young Talent Project [GDPPHYTP201902]

作者

  • C

    Chen, Jing-Hua (第一作者)

    2 · southern med univ · guangdong prov peoples hosp

  • C

    Chu, Xiang-Peng

    guangdong prov peoples hosp

查看全部 19 位作者收起作者
  • Z

    Zhang, Jia-Tao

    2 · southern med univ · guangdong prov peoples hosp

  • N

    Nie, Qiang

    guangdong prov peoples hosp

  • T

    Tang, Wen-Fang

    guangdong prov peoples hosp · shantou univ

  • S

    Su, Jian

    guangdong prov peoples hosp

  • Y

    Yan, Hong-Hong

    guangdong prov peoples hosp

  • Z

    Zheng, Hong-Ping

  • C

    Chen, Ze-Xin

  • C

    Chen, Xin

  • S

    Song, Meng-Meng

  • Y

    Yi, Xin

  • L

    Li, Pan-Song

  • G

    Guan, Yan-Fang

  • L

    Li, Gang

    2 · southern med univ

  • D

    Deng, Chu-Xia

  • R

    Rosell, Rafael

  • W

    Wu, Yi-Long

    guangdong prov peoples hosp

  • Z

    Zhong, Wen-Zhao (通讯)

    2 · southern med univ · guangdong prov peoples hosp

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417